Interview: Smeeta Sinha
European Medical Journal » Nephrology
by
1w ago
Smeeta Sinha National Clinical Director for Renal Medicine, NHS England, UK; Consultant Nephrologist, Northern Care Alliance NHS Foundation ..read more
Visit website
Renal Replacement Therapy
European Medical Journal » Nephrology
by
1w ago
End-stage liver disease (ESLD) represents a non-reversible, advanced stage of cirrhosis, where the hepatic architecture is distorted and ..read more
Visit website
Sparsentan for treatment of immunoglobulin A nephropathy: Latest study results
European Medical Journal » Nephrology
by
1w ago
Sparsentan for treatment of immunoglobulin A nephropathy: Latest study results In patients with immunoglobulin A nephropathy, use of the endothelin 1 Type A/Ang II subtype 1 receptor antagonist sparsentan can decrease proteinuria and preserve kidney function ..read more
Visit website
Membranous Nephropathy and Pulmonary Tuberculosis: An Uncommon Combination: Case Report
European Medical Journal » Nephrology
by
1M ago
Membranous Nephropathy and Pulmonary Tuberculosis: An Uncommon Combination: Case Report Mycobacterium tuberculosis causing glomerulonephritis (GN) is a rare occurrence, and its association has been seldom reported ..read more
Visit website
Current Treatment and Emerging Solutions in IgA Nephropathy
European Medical Journal » Nephrology
by
3M ago
Current Treatment and Emerging Solutions in IgA Nephropathy IgAN, which can lead to CKD and kidney failure, is the most common form of primary glomerulonephritis, predominantly ..read more
Visit website
Diagnosing Fabry Disease: Practical Clinical Recommendations and Guidance for Patients with Fabry Disease
European Medical Journal » Nephrology
by
7M ago
Diagnosing Fabry Disease: Practical Clinical Recommendations and Guidance for Patients with Fabry Disease This article was funded by Sanofi and is intended for healthcare professionals ..read more
Visit website
Recent Advances in Targeting Complement in Glomerular Disease
European Medical Journal » Nephrology
by
8M ago
Recent Advances in Targeting Complement in Glomerular Disease The complement system has been an appealing drug target for a long time. However, early drug development efforts have failed for ..read more
Visit website
Interview: Catherine Quinlan
European Medical Journal » Nephrology
by
8M ago
I only ever wanted to be a paediatrician, thanks to ER’s Doug Ross, and my first job was on the nephrology service in Temple Street ..read more
Visit website
Proteinuria as a Surrogate Endpoint for Disease Progression in IgA Nephropathy: Predicting Long-Term Treatment Effects of Sparsentan
European Medical Journal » Nephrology
by
8M ago
Proteinuria as a Surrogate Endpoint for Disease Progression in IgA Nephropathy: Predicting Long-Term Treatment Effects of Sparsentan IgA nephropathy (IgAN) is a rare, life-limiting disease for which there is significant unmet need. Until recently, drug development for ..read more
Visit website
Filling the Gap by Targeting the Gut: First Disease-Modifying Treatment Approved for IgA Nephropathy
European Medical Journal » Nephrology
by
8M ago
Filling the Gap by Targeting the Gut: First Disease-Modifying Treatment Approved for IgA Nephropathy Bengt Fellström, Uppsala University, Sweden, described the relationship between IgA nephropathy (IgAN) and gastrointestinal mucosal ..read more
Visit website

Follow European Medical Journal » Nephrology on FeedSpot

Continue with Google
Continue with Apple
OR